Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Jan 29, 2026

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	8,027,281	8,027,281	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	8,027,281	0	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	8,027,281	8,027,281	-		0	Class A Common Stock
UWM Holdings Corp (Class A)	Mathew Ishbia	Director, President and CEO, Ten Percent Owner		29 Jan 2026	6,600,000	7,489,517	-		-	Class A Common Stock
UWM Holdings Corp (Class A)	Mathew Ishbia	Director, President and CEO, Ten Percent Owner		29 Jan 2026	6,600,000	1,311,682,620	-		-	UWM Paired Interests
Ethos Technologies Inc Board Meeting	Peter George Colis	Director, CEO and Secretary		29 Jan 2026	6,154,683	811,183	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Peter George Colis	Director, CEO and Secretary		29 Jan 2026	6,154,683	6,154,683	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	4,767,653	0	-		-	Series A Preferred Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	3,943,281	3,943,281	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	3,943,281	811,183	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	2,132,408	2,132,408	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	2,132,408	0	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	2,132,408	2,132,408	-		0	Class A Common Stock
Erasca Inc	Jonathan E. Lim	Director, Chairman & CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	2,000,000	2,000,000	-		-	Stock option (right to buy)
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	1,917,944	0	-		-	Series C Preferred Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	1,897,656	0	-		-	Series A-2 Preferred Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	1,238,282	1,238,282	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	1,238,282	0	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	1,238,282	1,238,282	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	1,124,709	0	-		-	Series B Preferred Stock
Invivyd Inc	Jill Andersen	Chief Legal Officer, Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	820,000	820,000	-		-	Stock Option (Right to Buy)
Celestica Inc	Robert A. Mionis	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	780,376	780,376	-		-	Performance Share Units
AT&T Legal Settlement	John T. Stankey	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	767,250	843,371 (0%)	0%		-	Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	733,307	0	-		-	Series A Preferred Stock
AGNC Investment Corp	Gary D. Kain	Director, Director, Executive Chair	Sale of securities on an exchange or to another person at price $ 11.91 per share.	29 Jan 2026	700,000	2,189,091 (0%)	0%	11.9	8,336,300	Common Stock
Invivyd Inc	Julie Green	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	675,000	675,000	-		-	Stock Option (Right to Buy)
Invivyd Inc	Timothy Lee	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	675,000	675,000	-		-	Stock Option (Right to Buy)
Cibus Inc (Class A)	Jean-Pierre Jules Lehmann	Director	Grant, award, or other acquisition of securities at price $ 1.50 per share.	29 Jan 2026	666,666	699,156 (2%)	2%	1.5	999,999	Class A Common Stock
UWM Holdings Corp (Class A)	Mathew Ishbia	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 5.00 per share.	29 Jan 2026	632,874	889,517	-	5	3,164,370	Class A Common Stock
UWM Holdings Corp (Class A)	Mathew Ishbia	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 5.76 per share.	29 Jan 2026	632,874	1,522,391	-	5.8	3,645,354	Class A Common Stock
UWM Holdings Corp (Class A)	Mathew Ishbia	Director, President and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 5.20 per share.	29 Jan 2026	632,874	6,856,643	-	5.2	3,290,945	Class A Common Stock
Erasca Inc	Shannon R. Morris	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	625,000	625,000	-		-	Stock option (right to buy)
Invivyd Inc	William Duke	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	625,000	625,000	-		-	Stock Option (Right to Buy)
Invivyd Inc	Robert D. Allen	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	625,000	625,000	-		-	Stock Option (Right to Buy)
Ethos Technologies Inc Board Meeting	Peter George Colis	Director, CEO and Secretary	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	29 Jan 2026	562,993	6,965,866	-		0	Class A Common Stock
Erasca Inc	Ebun S. Garner	General Counsel & Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	560,000	560,000	-		-	Stock option (right to buy)
Solid Biosciences Inc	Alexander G. Cumbo	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	509,850	509,850	-		-	Employee Stock Option (Right to Buy)
AT&T Legal Settlement	Jeffery S. McElfresh	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	418,500	589,251 (0%)	0%		-	Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	29 Jan 2026	410,726	4,754,464	-		0	Class A Common Stock
Scynexis Inc	David Angulo	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	391,333	1,244,431 (1%)	0%		0	Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	388,726	388,726	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	388,726	0	-		0	Class A Common Stock
KLX Energy Services Holdings Inc	Christopher J. Baker	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	355,965	384,156	-		-	Restricted Stock Unit
AT&T Legal Settlement	Pascal Desroches	Sr. Exec VP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	348,750	488,490 (0%)	0%		-	Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	337,996	337,996	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	337,996	0	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	337,996	337,996	-		0	Class A Common Stock
Cibus Inc (Class A)	Rory B. Riggs	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 1.50 per share.	29 Jan 2026	333,333	14,916,640 (45%)	1%	1.5	500,000	Class A Common Stock
AT&T Legal Settlement	David R. McAtee	Sr. Exec. VP and Gen. Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	325,500	325,500 (0%)	0%		-	Common Stock
AT&T Legal Settlement	John T. Stankey	Director, CEO & President	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	307,123	234,335 (0%)	0%	25.1	7,718,004	Common Stock
AT&T Legal Settlement	John T. Stankey	Director, CEO & President	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	307,122	234,334 (0%)	0%	25.1	7,717,999	Common Stock
AT&T Legal Settlement	John T. Stankey	Director, CEO & President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	301,913	541,457 (0%)	0%	25.1	7,587,086	Common Stock
AT&T Legal Settlement	John T. Stankey	Director, CEO & President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	301,912	541,458 (0%)	0%	25.1	7,587,071	Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	291,875	0	-		-	Series A-2 Preferred Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	291,545	291,545	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	291,545	0	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	291,545	0	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	291,545	291,545	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	291,545	291,545	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	291,545	0	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	291,544	291,544	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	291,544	291,544	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	291,544	291,544	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	291,544	0	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	291,544	0	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	291,544	0	-		0	Class A Common Stock
Core Scientific Inc - Ordinary Shares - New	Adam Taylor Sullivan	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.79 per share.	29 Jan 2026	274,554	4,131,150	-	18.8	5,158,870	Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 19.00 per share.	29 Jan 2026	260,525	260,525	-	19	4,949,975	Class A Common Stock
Solid Biosciences Inc	Alexander G. Cumbo	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	254,900	254,900	-		-	Restricted Stock Units
Zevra Therapeutics Inc	Neil F. McFarlane	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	250,000	250,000	-		-	Stock Option (right to buy)
AT&T Legal Settlement	Lori M. Lee	Global Mktg Ofr & SEVP Intl	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	238,313	249,390 (0%)	0%		-	Common Stock
Zevra Therapeutics Inc	Neil F. McFarlane	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	233,334	233,333	-		-	Restricted Stock Unit
Zevra Therapeutics Inc	Neil F. McFarlane	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	233,334	455,350 (0%)	0%		-	Common Stock
AT&T Legal Settlement	John T. Stankey	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	228,810	228,810	-		-	Restricted Stock Units (2026)
Ethos Technologies Inc Board Meeting	Peter George Colis	Director, CEO and Secretary		29 Jan 2026	214,822	214,822	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Peter George Colis	Director, CEO and Secretary		29 Jan 2026	214,822	0	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	214,464	0	-		-	Series D Preferred Stock
Ethos Technologies Inc Board Meeting	Vipul Sharma	Chief Technology Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	29 Jan 2026	212,132	729,217	-		0	Class A Common Stock
Solid Biosciences Inc	David Tyronne Howton	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	210,200	210,200	-		-	Employee Stock Option (Right to Buy)
Solid Biosciences Inc	Gabriel Brooks	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	207,450	207,450	-		-	Employee Stock Option (Right to Buy)
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	200,936	0	-		-	Series A Preferred Stock
T3 Defense Inc Ordinary	Menachem Shalom	Director, CEO, Ten Percent Owner		29 Jan 2026	200,000	3,442,010	-	1.5	300,000	Common Stock $0.0001 par value per share
T3 Defense Inc Ordinary	Menachem Shalom	Director, CEO, Ten Percent Owner		29 Jan 2026	200,000	4,818,359	-		-	Common Stock Purchase Warrants
Hycroft Mining Holding Corp (Class A)	Eric Steven Sprott	Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 45.99 per share.	29 Jan 2026	200,000	36,753,704	-	46.0	9,198,000	Class A common stock
Ethos Technologies Inc Board Meeting	Vipul Sharma	Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 17.86 per share.	29 Jan 2026	200,000	529,217	-	17.9	3,572,000	Class A Common Stock
Hemab Therapeutics Holdings 10-year high	Mads Behrndt-Eriksen	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	195,206	195,206	-		-	Warrants (Right to Buy)
Solid Biosciences Inc	Jessie Hanrahan	Chief Regulatory Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	190,000	190,000	-		-	Employee Stock Option (Right to Buy)
Solid Biosciences Inc	Kevin Tan	CFO & Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	187,000	187,000	-		-	Employee Stock Option (Right to Buy)
Celestica Inc	Mandeep Chawla	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	183,674	183,674	-		-	Performance Share Units
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	180,988	0	-		-	Series C Preferred Stock
Beam Therapeutics Inc	John Evans	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	180,000	180,000	-		-	Stock Option (Right to Buy)
Celestica Inc	Jason Phillips	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	174,254	174,254	-		-	Performance Share Units
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	172,989	0	-		-	Series B Preferred Stock
Solid Biosciences Inc	Paul Herzich	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	170,000	170,000	-		-	Employee Stock Option (Right to Buy)
Texas Instruments	Haviv Ilan	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	169,862	169,862	-		-	NQ Stock Option (Right to Buy)
Postal Realty Trust Inc - Ordinary Shares Cls A	Andrew Spodek	Director, CEO and Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	169,431	1,148,627	-		-	LTIP Units
Solid Biosciences Inc	Alexander G. Cumbo	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	169,401	250,789 (0%)	0%		-	Common Stock
Solid Biosciences Inc	Alexander G. Cumbo	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	169,401	0	-		-	Performance Stock Units
Solid Biosciences Inc	Alexander G. Cumbo	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	169,401	169,401	-		-	Restricted Stock Units
AT&T Legal Settlement	Jeffery S. McElfresh	Chief Operating Officer	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	167,521	257,049 (0%)	0%	25.1	4,209,812	Common Stock
AT&T Legal Settlement	Jeffery S. McElfresh	Chief Operating Officer	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	167,416	256,995 (0%)	0%	25.1	4,207,170	Common Stock
AT&T Legal Settlement	Jeffery S. McElfresh	Chief Operating Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	164,839	424,411 (0%)	0%	25.1	4,142,423	Common Stock
AT&T Legal Settlement	Jeffery S. McElfresh	Chief Operating Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	164,680	424,570 (0%)	0%	25.1	4,138,424	Common Stock
Celestica Inc	Todd C. Cooper	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	160,126	160,126	-		-	Performance Share Units
Celestica Inc	Yann L. Etienvre	Chief Operations Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	160,126	160,126	-		-	Performance Share Units
AT&T Legal Settlement	John T. Stankey	Director, CEO & President	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	158,214	76,121 (0%)	0%		-	Common Stock
AT&T Legal Settlement	Edward Oliver Gillespie	SEVP-Ext & Legislative Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	158,100	158,100 (0%)	0%		-	Common Stock
Clover Health Investments Corp (Class A)	Peter J. Kuipers	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.31 per share.	29 Jan 2026	156,856	5,758,353	-	2.3	362,337	Class A Common Stock
Artelo Biosciences Inc Board Meeting	Gregory D. Gorgas	Director, Pres, CEO, CFO, Treas & Secr	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	154,713	154,713	-		-	Stock Options (right to buy)
AT&T Legal Settlement	Jeremy Alan Legg	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	151,126	151,126 (0%)	0%		-	Common Stock
FREYR Battery	Einar Kilde	See Remarks below.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	146,797	146,797	-		-	Restricted Stock Units (RSUs)
PPL	Vincent Sorgi	President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.31 per share.	29 Jan 2026	146,265	662,262 (0%)	0%	36.3	5,310,882	Common Stock
PPL	Vincent Sorgi	President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	146,265	0	-		-	Performance Stock Unit (SIP)
Lithium Americas Corp	Jonathan D. Evans	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	146,107	146,107	-		-	Restricted Stock Units
Charles Schwab Results Board Meeting	Charles R. Schwab	Director, Co-Chairman	Sale of securities on an exchange or to another person at price $ 103.16 per share.	29 Jan 2026	145,650	55,947,329 (4%)	0%	103.2	15,025,968	Common Stock
Hemab Therapeutics Holdings 10-year high	Catherine Madigan	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	145,134	145,134	-		-	Warrants (Right to Buy)
KLX Energy Services Holdings Inc	Christopher J. Baker	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	144,033	494,381 (2%)	0%		0	Common stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	142,616	0	-		-	Series A-2 Preferred Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	142,616	0	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	142,616	142,616	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	142,616	142,616	-		-	Class B Common Stock
AT&T Legal Settlement	Pascal Desroches	Sr. Exec VP and CFO	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	139,601	211,655 (0%)	0%	25.1	3,508,177	Common Stock
AT&T Legal Settlement	Pascal Desroches	Sr. Exec VP and CFO	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	139,506	211,606 (0%)	0%	25.1	3,505,809	Common Stock
AT&T Legal Settlement	Pascal Desroches	Sr. Exec VP and CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	137,377	351,113 (0%)	0%	25.1	3,452,286	Common Stock
AT&T Legal Settlement	Pascal Desroches	Sr. Exec VP and CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	137,233	351,257 (0%)	0%	25.1	3,448,687	Common Stock
KLX Energy Services Holdings Inc	Max Bouthillette	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	133,070	143,218	-		-	Restricted Stock Unit
AT&T Legal Settlement	David R. McAtee	Sr. Exec. VP and Gen. Counsel	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	130,294	67,121 (0%)	0%	25.1	3,274,298	Common Stock
AT&T Legal Settlement	David R. McAtee	Sr. Exec. VP and Gen. Counsel	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	130,191	67,068 (0%)	0%	25.1	3,271,710	Common Stock
Scynexis Inc	Scott Sukenick	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	129,833	574,539 (0%)	0%		0	Common Stock
Scynexis Inc	Ivor Macleod	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	129,833	398,529 (0%)	0%		0	Common Stock
Ethos Technologies Inc Board Meeting	Peter George Colis	Director, CEO and Secretary		29 Jan 2026	128,893	0	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Peter George Colis	Director, CEO and Secretary		29 Jan 2026	128,893	128,893	-		-	Class B Common Stock
AT&T Legal Settlement	David R. McAtee	Sr. Exec. VP and Gen. Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	128,240	197,259 (0%)	0%	25.1	3,222,686	Common Stock
AT&T Legal Settlement	David R. McAtee	Sr. Exec. VP and Gen. Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	128,084	197,415 (0%)	0%	25.1	3,218,766	Common Stock
Zevra Therapeutics Inc	Neil F. McFarlane	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	125,000	125,000	-		-	Restricted Stock Unit
CMS Energy	Garrick J. Rochow	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	123,413	641,865 (0%)	0%		0	Common Stock
Ionis Pharma Inc	Brett P. Monia	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	122,214	346,897 (0%)	0%		0	Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	121,541	121,541	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	121,541	0	-		0	Class A Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	121,541	121,541	-		0	Class A Common Stock
First Horizon Corp Results Board Meeting	D. Bryan Jordan	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.43 per share.	29 Jan 2026	116,655	938,172 (0%)	0%	15.4	1,799,987	Common Stock
First Horizon Corp Results Board Meeting	D. Bryan Jordan	Director, Chairman, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	116,655	0	-		-	Stock Options (Right to Buy)
Tvardi Therapeutics Inc	Imran Nizamudin Alibhai	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	115,000	115,000	-		-	Employee Stock Option (right to buy)
Hemab Therapeutics Holdings 10-year high	John M. Maraganore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	107,338	107,338	-		-	Warrants (Right to Buy)
Lindblad Expeditions Holdings Inc	Sven-Olof Lindblad	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 16.84 per share.	29 Jan 2026	105,356	11,251,062 (22%)	0%	16.8	1,774,248	Common Stock
Solid Biosciences Inc	David Tyronne Howton	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	105,100	105,100	-		-	Restricted Stock Units
Solid Biosciences Inc	Gabriel Brooks	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	103,750	103,750	-		-	Restricted Stock Units
AT&T Legal Settlement	Kellyn Smith Kenny	Chief Marketing & Growth Ofcr	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	102,300	102,300 (0%)	0%		-	Common Stock
Solid Biosciences Inc	Alexander G. Cumbo	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	100,400	301,200	-		-	Restricted Stock Units
Solid Biosciences Inc	Alexander G. Cumbo	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	100,400	351,189 (0%)	0%		-	Common Stock
USA Rare Earth Inc (Class A)	Michael Blitzer	Director	Purchase of securities on an exchange or from another person at price $ 21.44 per share.	29 Jan 2026	100,000	847,500	-	21.4	2,143,860	Common Stock, par value $0.0001 per share
MVB Fin Corp	Larry F. Mazza	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.50 per share.	29 Jan 2026	100,000	726,358 (6%)	0%	12.5	1,250,000	Common Stock
MVB Fin Corp	Larry F. Mazza	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	100,000	0	-		-	Common Stock Options
Netflix Results Board Meeting	Gregory K. Peters	Director, Co-CEO	Sale of securities on an exchange or to another person at price $ 82.87 per share.	29 Jan 2026	98,221	129,700 (0%)	0%	82.9	8,139,849	Common Stock
Erasca Inc	Michael D. Varney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	96,000	96,000	-		-	Stock option (right to buy)
Archrock Inc	D. Bradley Childers	Director, PRESIDENT AND CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	95,989	2,220,640 (1%)	0%		0	Common Stock
AT&T Legal Settlement	Lori M. Lee	Global Mktg Ofr & SEVP Intl	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	95,394	60,219 (0%)	0%	25.1	2,397,259	Common Stock
AT&T Legal Settlement	Lori M. Lee	Global Mktg Ofr & SEVP Intl	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	95,246	60,143 (0%)	0%	25.1	2,393,547	Common Stock
Solid Biosciences Inc	Jessie Hanrahan	Chief Regulatory Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	95,000	95,000	-		-	Restricted Stock Units
AT&T Legal Settlement	Jeffery S. McElfresh	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	94,509	94,509	-		-	Restricted Stock Units (2026)
AT&T Legal Settlement	Lori M. Lee	Global Mktg Ofr & SEVP Intl	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	94,000	155,390 (0%)	0%	25.1	2,362,233	Common Stock
AT&T Legal Settlement	Lori M. Lee	Global Mktg Ofr & SEVP Intl	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	93,776	155,613 (0%)	0%	25.1	2,356,612	Common Stock
Solid Biosciences Inc	Kevin Tan	CFO & Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	93,500	93,500	-		-	Restricted Stock Units
FREYR Battery	Einar Kilde	See Remarks below.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	92,910	92,910	-		-	Restricted Stock Units (RSUs)
Postal Realty Trust Inc - Ordinary Shares Cls A	Jeremy Garber	Pres., Treasurer & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	91,288	309,176	-		-	LTIP Units
Zevra Therapeutics Inc	Neil F. McFarlane	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 9.38 per share.	29 Jan 2026	91,000	364,350 (0%)	0%	9.4	853,425	Common Stock
Noble Corp PLC (Class A)	Robert W. Eifler	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	86,893	202,819	-		-	Restricted Stock Units
AT&T Legal Settlement	Jeffery S. McElfresh	Chief Operating Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	86,298	170,751 (0%)	0%		-	Common Stock
AT&T Legal Settlement	Jeffery S. McElfresh	Chief Operating Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	86,244	170,751 (0%)	0%		-	Common Stock
Solid Biosciences Inc	Paul Herzich	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	85,000	85,000	-		-	Restricted Stock Units
AT&T Legal Settlement	Pascal Desroches	Sr. Exec VP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	84,560	84,560	-		-	Restricted Stock Units (2026)
Entergy	Andrew S. Marsh	Director, Chair and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	84,502	84,502	-		-	Employee Stock Option (Right to Buy)
FREYR Battery	Jaime Eduardo Gualy	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	84,460	84,460	-		-	Restricted Stock Units (RSUs)
HCA Healthcare	Samuel N. Hazen	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	84,360	0	-		-	Stock Appreciation Right
HCA Healthcare	Samuel N. Hazen	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.96 per share.	29 Jan 2026	84,360	116,636 (0%)	0%	82.0	6,914,146	Common Stock
PPL	Vincent Sorgi	President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	84,288	84,288	-		-	Performance Stock Unit (SIP)
Lithium Americas Corp	Jonathan D. Evans	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	82,172	768,844	-		0	Common Shares
Solid Biosciences Inc	Alexander G. Cumbo	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 6.44 per share.	29 Jan 2026	80,258	270,931 (0%)	0%	6.4	516,613	Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	79,975	0	-		-	Series A-2 Preferred Stock
Solid Biosciences Inc	David Tyronne Howton	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	79,341	112,249 (0%)	0%		-	Common Stock
Solid Biosciences Inc	David Tyronne Howton	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	79,341	0	-		-	Performance Stock Units
Solid Biosciences Inc	David Tyronne Howton	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	79,341	79,341	-		-	Restricted Stock Units
Lindblad Expeditions Holdings Inc	Sven-Olof Lindblad	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 16.66 per share.	29 Jan 2026	78,283	11,172,779 (22%)	0%	16.7	1,304,148	Common Stock
Lithium Americas Corp	Kelvin Dushnisky	Director, EVP, Capital Projects	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	75,573	75,573	-		-	Restricted Share Units
Zevra Therapeutics Inc	Rahsaan W. Thompson	Chief Legal & Compliance, Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	75,000	75,000	-		-	Stock Option (right to buy)
Zevra Therapeutics Inc	Adrian Quartel	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	75,000	75,000	-		-	Stock Option (right to buy)
Zevra Therapeutics Inc	Joshua Schafer	CCO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	75,000	75,000	-		-	Stock Option (right to buy)
O'Reilly Automotive	Brad W. Beckham	CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	74,764	74,764	-		-	Nonqualified employee stock options (right to buy)
AT&T Legal Settlement	David R. McAtee	Sr. Exec. VP and Gen. Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	74,612	74,612	-		-	Restricted Stock Units (2026)
Lithium Americas Corp	Kelvin Dushnisky	Director, EVP, Capital Projects	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	74,587	252,544	-		0	Common Shares
Las Vegas Sands	Robert Glen Goldstein	Director, Chairman & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	73,415	75,639	-		-	Restricted Stock Units
Las Vegas Sands	Robert Glen Goldstein	Director, Chairman & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	73,415	73,415 (0%)	0%		0	Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	72,174	0	-		-	Series A Preferred Stock
AT&T Legal Settlement	Pascal Desroches	Sr. Exec VP and CFO	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	71,915	139,740 (0%)	0%		-	Common Stock
AT&T Legal Settlement	Pascal Desroches	Sr. Exec VP and CFO	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	71,866	139,740 (0%)	0%		-	Common Stock
AT&T Legal Settlement	Edward Oliver Gillespie	SEVP-Ext & Legislative Affairs	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	71,302	86,797 (0%)	0%	25.1	1,791,822	Common Stock
DexCom	Kevin R. Sayer	Director, Executive Chair	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	71,218	443,247 (0%)	0%		0	Common Stock
AT&T Legal Settlement	Edward Oliver Gillespie	SEVP-Ext & Legislative Affairs	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	69,666	88,433 (0%)	0%	25.1	1,750,729	Common Stock
AT&T Legal Settlement	Jeremy Alan Legg	Chief Technology Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	67,310	83,815 (0%)	0%	25.1	1,691,509	Common Stock
Caesars Entertainment	Thomas R. Reeg	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	67,185	388,669 (0%)	0%		0	Common Stock
AT&T Legal Settlement	David R. McAtee	Sr. Exec. VP and Gen. Counsel	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	67,121	0 (0%)	0%		-	Common Stock
AT&T Legal Settlement	David R. McAtee	Sr. Exec. VP and Gen. Counsel	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	67,068	0 (0%)	0%		-	Common Stock
PPL	Vincent Sorgi	President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	66,087	0	-		-	Performance Stock Unit (SIP)
PPL	Vincent Sorgi	President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.31 per share.	29 Jan 2026	66,087	544,924 (0%)	0%	36.3	2,399,619	Common Stock
Brinker Intl Inc	Kevin D. Hochman	Director, Pres. & CEO	Sale of securities on an exchange or to another person at price $ 160.31 per share.	29 Jan 2026	66,000	129,824 (0%)	0%	160.3	10,580,460	Common Stock
AT&T Legal Settlement	Jeremy Alan Legg	Chief Technology Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	65,534	85,591 (0%)	0%	25.1	1,646,887	Common Stock
FREYR Battery	Andreas Bentzen	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	65,030	65,030	-		-	Restricted Stock Units (RSUs)
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	64,043	64,043	-		-	Class B Common Stock
Ethos Technologies Inc Board Meeting	Lingke Wang	Director, President		29 Jan 2026	64,043	0	-		0	Class A Common Stock
PPL	Vincent Sorgi	President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.31 per share.	29 Jan 2026	64,021	598,241 (0%)	0%	36.3	2,324,603	Common Stock
Graco Inc	Mark W. Sheahan	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.85 per share.	29 Jan 2026	63,510	159,228 (0%)	0%	23.8	1,514,504	Common Stock
Graco Inc	Mark W. Sheahan	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	63,510	0	-		-	Non-qualified Stock Option (Right to Buy)
Ionis Pharma Inc	Brett P. Monia	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 82.72 per share.	29 Jan 2026	62,970	283,927 (0%)	0%	82.7	5,208,979	Common Stock
Keycorp	Angela G. Mago	Chief Human Resources Officer	Sale of securities on an exchange or to another person at price $ 21.55 per share.	29 Jan 2026	62,850	261,415 (0%)	0%	21.6	1,354,418	Common Shares
Keycorp	Angela G. Mago	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.49 per share.	29 Jan 2026	62,850	324,265 (0%)	0%	10.5	659,297	Common Shares
Keycorp	Angela G. Mago	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	62,850	0	-		-	Option to Buy
FREYR Battery	Andrew Munro	Chief Legal & Policy Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	62,110	62,110	-		-	Restricted Stock Units (RSUs)
Celestica Inc	Leila Wong	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	61,224	61,224	-		-	Performance Share Units
Graco Inc	David M. Lowe	CFO and Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.85 per share.	29 Jan 2026	60,510	698,849 (0%)	0%	23.8	1,442,964	Common Stock
Graco Inc	David M. Lowe	CFO and Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	60,510	3,000	-		-	Non-qualified Stock Option (Right to Buy)
Waste Management	James C. Fish	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 226.41 per share.	29 Jan 2026	59,516	279,603 (0%)	0%	226.4	13,475,018	Common Stock
Solid Biosciences Inc	Gabriel Brooks	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	58,847	0	-		-	Performance Stock Units
Solid Biosciences Inc	Gabriel Brooks	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	58,847	96,818 (0%)	0%		-	Common Stock
Solid Biosciences Inc	Gabriel Brooks	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	58,847	58,847	-		-	Restricted Stock Units
AT&T Legal Settlement	Edward Oliver Gillespie	SEVP-Ext & Legislative Affairs	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	58,366	30,067 (0%)	0%	25.1	1,466,740	Common Stock
AT&T Legal Settlement	Edward Oliver Gillespie	SEVP-Ext & Legislative Affairs	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	57,286	29,511 (0%)	0%	25.1	1,439,620	Common Stock
Las Vegas Sands	Robert Glen Goldstein	Director, Chairman & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	57,273	130,688 (0%)	0%		0	Common Stock
Las Vegas Sands	Robert Glen Goldstein	Director, Chairman & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	57,273	0	-		-	Restricted Stock Units
Solid Biosciences Inc	Kevin Tan	CFO & Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	56,647	56,647	-		-	Restricted Stock Units
Solid Biosciences Inc	Kevin Tan	CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	56,646	102,746 (0%)	0%		-	Common Stock
Solid Biosciences Inc	Kevin Tan	CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	56,646	0	-		-	Performance Stock Units
KLX Energy Services Holdings Inc	Max Bouthillette	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	56,584	199,449 (0%)	0%		0	Common stock
AT&T Legal Settlement	Jeremy Alan Legg	Chief Technology Officer	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	56,490	29,101 (0%)	0%	25.1	1,419,607	Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	56,275	0	-		-	Series D Preferred Stock
HCA Healthcare	Samuel N. Hazen	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	55,846	55,846	-		-	Stock Appreciation Right
AT&T Legal Settlement	Lori M. Lee	Global Mktg Ofr & SEVP Intl	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	55,710	55,710	-		-	Restricted Stock Units (2026)
Lithium Americas Corp	Richard Gerspacher	EVP, Capital Projects	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	55,403	55,403	-		-	Restricted Share Units
AT&T Legal Settlement	Jeremy Alan Legg	Chief Technology Officer	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	55,318	28,497 (0%)	0%	25.1	1,390,164	Common Stock
Solid Biosciences Inc	Paul Herzich	Chief Technology Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	54,925	81,547 (0%)	0%		-	Common Stock
Solid Biosciences Inc	Paul Herzich	Chief Technology Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	54,925	0	-		-	Performance Stock Units
Solid Biosciences Inc	Jessie Hanrahan	Chief Regulatory Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	54,925	81,585 (0%)	0%		-	Common Stock
Solid Biosciences Inc	Jessie Hanrahan	Chief Regulatory Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	54,925	0	-		-	Performance Stock Units
Solid Biosciences Inc	Paul Herzich	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	54,925	54,925	-		-	Restricted Stock Units
Solid Biosciences Inc	Jessie Hanrahan	Chief Regulatory Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	54,925	54,925	-		-	Restricted Stock Units
Caesars Entertainment	Anthony L. Carano	President and COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	53,398	323,881 (0%)	0%		0	Common Stock
Mind Medicine Inc	Roger Adsett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	50,000	50,000	-		-	Stock Option (Right to Buy)
Aureus Greenway Holdings Inc Board Meeting	Xinyue Jasmine Geffner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	50,000	50,000	-	0.0	50	Common Stock
Aureus Greenway Holdings Inc Board Meeting	Vuk Jeremic	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	50,000	50,000	-	0.0	50	Common Stock
SEI Investments Co. 10-year high	Ryan P. Hicke	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 87.39 per share.	29 Jan 2026	49,937	210,217 (0%)	0%	87.4	4,363,994	Common Stock
Caesars Entertainment	Thomas R. Reeg	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	49,269	289,688 (0%)	0%		0	Common Stock
Caesars Entertainment	Thomas R. Reeg	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	49,269	98,540	-		-	Restricted Stock Units
AT&T Legal Settlement	Lori M. Lee	Global Mktg Ofr & SEVP Intl	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	49,142	11,077 (0%)	0%		-	Common Stock
AT&T Legal Settlement	Lori M. Lee	Global Mktg Ofr & SEVP Intl	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	49,066	11,077 (0%)	0%		-	Common Stock
Hemab Therapeutics Holdings 10-year high	Catherine Madigan	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	49,016	49,016	-		-	Stock Option (Right to Buy)
Hemab Therapeutics Holdings 10-year high	Mads Behrndt-Eriksen	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	49,016	49,016	-		-	Stock Option (Right to Buy)
Texas Instruments	Haviv Ilan	Director, Chairman, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	47,952	214,168 (0%)	0%		0	Common Stock
Texas Instruments	Hagop H. Kozanian	Sr. Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	47,723	47,723	-		-	NQ Stock Option (Right to Buy)
Texas Instruments	Amichai Ron	Sr. Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	47,723	47,723	-		-	NQ Stock Option (Right to Buy)
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	47,400	0	-		-	Series B Preferred Stock
Texas Instruments	Mohammad Yunus	Sr. Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	46,915	46,915	-		-	NQ Stock Option (Right to Buy)
Lithium Americas Corp	Luke Colton	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	46,496	46,496	-		-	Restricted Share Units
Applied Digital Corp	Chuck Hastings	Director	Sale of securities on an exchange or to another person at price $ 38.57 per share.	29 Jan 2026	45,987	388,372	-	38.6	1,773,719	Common Stock
Tvardi Therapeutics Inc	Avi Daniel Conn	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	45,000	45,000	-		-	Employee Stock Option (right to buy)
Tvardi Therapeutics Inc	John Saewook Kauh	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	45,000	45,000	-		-	Employee Stock Option (right to buy)
PPL	Joseph P. Bergstein	EVP and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	44,910	0	-		-	Performance Stock Unit (SIP)
PPL	Joseph P. Bergstein	EVP and CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.31 per share.	29 Jan 2026	44,910	220,101 (0%)	0%	36.3	1,630,682	Common Stock
Texas Instruments	Rafael R. Lizardi	Sr. Vice President & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	44,488	44,488	-		-	NQ Stock Option (Right to Buy)
Texas Instruments	Mark T. Roberts	Sr. Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	44,488	44,488	-		-	NQ Stock Option (Right to Buy)
Lithium Americas Corp	Richard Gerspacher	EVP, Capital Projects	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	44,434	137,862	-		0	Common Shares
Caesars Entertainment	Bret Yunker	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	44,272	219,599 (0%)	0%		0	Common Stock
PubMatic Inc Ordinary Shares	Rajeev K. Goel	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 7.26 per share.	29 Jan 2026	44,000	0	-	7.3	319,268	Class A Common Stock
AT&T Legal Settlement	Kellyn Smith Kenny	Chief Marketing & Growth Ofcr	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	42,725	22,009 (0%)	0%	25.1	1,073,682	Common Stock
AT&T Legal Settlement	Jeremy Alan Legg	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	42,280	42,280	-		-	Restricted Stock Units (2026)
Solid Biosciences Inc	David Tyronne Howton	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	42,275	126,825	-		-	Restricted Stock Units
Solid Biosciences Inc	David Tyronne Howton	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	42,275	154,254 (0%)	0%		-	Common Stock
PubMatic Inc Ordinary Shares	Rajeev K. Goel	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	42,203	42,203	-		0	Class A Common Stock
PubMatic Inc Ordinary Shares	Rajeev K. Goel	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	42,203	0	-		-	Restricted Stock Unit
PPL	Vincent Sorgi	President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	42,144	42,144	-		-	Stock Unit (SIP)
PPL	Vincent Sorgi	President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	42,144	42,144	-		-	Performance Stock Unit (SIP)
PPL	Vincent Sorgi	President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	42,144	42,144	-		-	Performance Stock Unit (SIP)
HCA Healthcare	Samuel N. Hazen	Director, CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 488.27 per share.	29 Jan 2026	41,483	75,153 (0%)	0%	488.3	20,254,904	Common Stock
AT&T Legal Settlement	Kellyn Smith Kenny	Chief Marketing & Growth Ofcr	Sale or transfer of securities back to the company at price $ 25.13 per share.	29 Jan 2026	41,299	21,275 (0%)	0%	25.1	1,037,854	Common Stock
Texas Instruments	Mark Gary	Sr. Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	40,444	40,444	-		-	NQ Stock Option (Right to Buy)
Graco Inc	Mark W. Sheahan	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.83 per share.	29 Jan 2026	40,219	119,009 (0%)	0%	86.8	3,492,216	Common Stock
Viemed Healthcare Inc	Casey Hoyt	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	39,795	39,795	-		-	Restricted Stock Units
Viemed Healthcare Inc	Casey Hoyt	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	39,795	364,377	-		-	Common Shares
AT&T Legal Settlement	Kellyn Smith Kenny	Chief Marketing & Growth Ofcr	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	39,725	62,574 (0%)	0%	25.1	998,304	Common Stock
KLX Energy Services Holdings Inc	Christopher J. Baker	Director, See Remarks	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.78 per share.	29 Jan 2026	39,655	454,726 (1%)	0%	2.8	110,241	Common stock
Public Policy Holding Company	Zachary Wayne Williams	Executive Director	Sale of securities on an exchange or to another person at price $ 12.25 per share.	29 Jan 2026	39,032	930,749 (3%)	0%	12.3	478,142	Ords 0.00p
Graco Inc	David M. Lowe	CFO and Treasurer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.83 per share.	29 Jan 2026	38,325	660,524 (0%)	0%	86.8	3,327,760	Common Stock
Solid Biosciences Inc	David Tyronne Howton	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 6.44 per share.	29 Jan 2026	37,771	116,753 (0%)	0%	6.4	243,128	Common Stock
Archrock Inc	Douglas S. Aron	SR VICE PRESIDENT, CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	37,709	599,162 (0%)	0%		0	Common Stock
Las Vegas Sands	Patrick Dumont Sydney	Director, President & COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	37,649	484,257 (0%)	0%		0	Common Stock
Las Vegas Sands	Patrick Dumont Sydney	Director, President & COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	37,649	38,789	-		-	Restricted Stock Units
AT&T Legal Settlement	Kellyn Smith Kenny	Chief Marketing & Growth Ofcr	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.13 per share.	29 Jan 2026	37,565	64,734 (0%)	0%	25.1	944,031	Common Stock
Lithium Americas Corp	Luke Colton	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	37,554	37,554	-		0	Common Shares
Zevra Therapeutics Inc	Rahsaan W. Thompson	Chief Legal & Compliance, Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	37,500	37,500	-		-	Restricted Stock Unit
Zevra Therapeutics Inc	Adrian Quartel	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	37,500	37,500	-		-	Restricted Stock Unit
Zevra Therapeutics Inc	Joshua Schafer	CCO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	37,500	37,500	-		-	Restricted Stock Unit
Aeluma Inc	Mark N. Tompkins	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 15.74 per share.	29 Jan 2026	37,500	1,824,988	-	15.7	590,250	Common Stock
Artelo Biosciences Inc Board Meeting	Mark Edward Spring	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	36,391	36,391	-		-	Stock Options (right to buy)
AT&T Legal Settlement	Darcie Henry Cakaric	SEVP and Chief HR Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	35,814	35,814	-		-	Restricted Stock Units (2026)
Zevra Therapeutics Inc	Joshua Schafer	CCO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	35,334	35,333	-		-	Restricted Stock Unit
Zevra Therapeutics Inc	Joshua Schafer	CCO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	35,334	72,778 (0%)	0%		-	Common Stock
AT&T Legal Settlement	Edward Oliver Gillespie	SEVP-Ext & Legislative Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	34,819	34,819	-		-	Restricted Stock Units (2026)
AT&T Legal Settlement	Kellyn Smith Kenny	Chief Marketing & Growth Ofcr	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	34,819	34,819	-		-	Restricted Stock Units (2026)
Caesars Entertainment	Thomas R. Reeg	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	34,639	34,639	-		-	Restricted Stock Units
Northern Trust 10-year high	Michael G. O'Grady	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.25 per share.	29 Jan 2026	34,489	383,557 (0%)	0%	58.2	2,008,984	Common Stock
Northern Trust 10-year high	Michael G. O'Grady	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	34,489	0	-		-	Employee Stock Option (right-to-buy)
DexCom	Kevin R. Sayer	Director, Executive Chair	Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.36 per share.	29 Jan 2026	34,257	408,990 (0%)	0%	73.4	2,513,094	Common Stock
Lithium Americas Corp	Edward Grandy	Sr VP, GC & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	33,655	173,372	-		0	Common Shares
Lindblad Expeditions Holdings Inc	Benjamin Bressler	*Founder & CEO of NHA	Sale of securities on an exchange or to another person at price $ 17.02 per share.	29 Jan 2026	33,338	23,466 (0%)	0%	17.0	567,473	Common Stock
Lindblad Expeditions Holdings Inc	Benjamin Bressler	*Founder & CEO of NHA	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	33,338	56,804 (0%)	0%		0	Common Stock
Lindblad Expeditions Holdings Inc	Benjamin Bressler	*Founder & CEO of NHA	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	33,338	309,867	-		-	Stock Option (right to buy)
CMS Energy	Rejji P. Hayes	EVP/CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	33,144	269,725 (0%)	0%		0	Common Stock
Solid Biosciences Inc	Kevin Tan	CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	33,075	99,225	-		-	Restricted Stock Units
Solid Biosciences Inc	Kevin Tan	CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	33,075	135,821 (0%)	0%		-	Common Stock
Enphase Energy	Badri Kothandaraman	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	33,000	143,420 (0%)	0%		0	Common Stock
Lithium Americas Corp	Edward Grandy	Sr VP, GC & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	32,971	32,971	-		-	Restricted Share Units
Caesars Entertainment	Thomas R. Reeg	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	32,546	0	-		-	Restricted Stock Units
O'Reilly Automotive	Brent Gentry Kirby	PRESIDENT	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	32,507	32,507	-		-	Nonqualified employee stock options (right to buy)
Lithium Americas Corp	Alexi Zawadzki	VP, Resource Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	31,647	96,986	-		0	Common Shares
PPL	Wendy E. Stark	EVP & CLO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.31 per share.	29 Jan 2026	31,092	107,778 (0%)	0%	36.3	1,128,951	Common Stock
PPL	Wendy E. Stark	EVP & CLO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	31,092	0	-		-	Performance Stock Unit (SIP)
AT&T Legal Settlement	Edward Oliver Gillespie	SEVP-Ext & Legislative Affairs	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	30,067	0 (0%)	0%		-	Common Stock
Yelp Inc	Jeremy Stoppelman	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.47 per share.	29 Jan 2026	30,000	786,458 (1%)	0%	20.5	614,100	Common Stock
Yelp Inc	Jeremy Stoppelman	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	30,000	66,200	-		-	Stock Option (Right to Buy)
Yelp Inc	Jeremy Stoppelman	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	30,000	96,200	-		-	Stock Option (Right to Buy)
Yelp Inc	Jeremy Stoppelman	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	30,000	126,200	-		-	Stock Option (Right to Buy)
Yelp Inc	Jeremy Stoppelman	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 27.54 per share.	29 Jan 2026	30,000	756,458 (1%)	0%	27.5	826,089	Common Stock
Yelp Inc	Jeremy Stoppelman	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.47 per share.	29 Jan 2026	30,000	786,458 (1%)	0%	20.5	614,100	Common Stock
Yelp Inc	Jeremy Stoppelman	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 27.26 per share.	29 Jan 2026	30,000	756,458 (1%)	0%	27.3	817,872	Common Stock
Yelp Inc	Jeremy Stoppelman	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.47 per share.	29 Jan 2026	30,000	786,458 (1%)	0%	20.5	614,100	Common Stock
Yelp Inc	Jeremy Stoppelman	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 27.35 per share.	29 Jan 2026	30,000	756,458 (1%)	0%	27.3	820,389	Common Stock
QuantumScape Corp (Class A)	Geoffrey G. Ribar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	29,878	29,878	-		0	Class A Common Stock
AT&T Legal Settlement	Edward Oliver Gillespie	SEVP-Ext & Legislative Affairs	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	29,511	0 (0%)	0%		-	Common Stock
Las Vegas Sands	Patrick Dumont Sydney	Director, President & COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	29,370	0	-		-	Restricted Stock Units
Las Vegas Sands	Patrick Dumont Sydney	Director, President & COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	29,370	501,657 (0%)	0%		0	Common Stock
O'Reilly Automotive	Jeremy A. Fletcher	EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	29,256	29,256	-		-	Nonqualified employee stock options (right to buy)
AT&T Legal Settlement	Jeremy Alan Legg	Chief Technology Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	29,101	0 (0%)	0%		-	Common Stock
PPL	Vincent Sorgi	President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.31 per share.	29 Jan 2026	28,927	515,997 (0%)	0%	36.3	1,050,339	Common Stock
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	28,725	0	-		-	Series A-2 Preferred Stock
AT&T Legal Settlement	Jeremy Alan Legg	Chief Technology Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	28,497	0 (0%)	0%		-	Common Stock
Solid Biosciences Inc	Gabriel Brooks	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 6.44 per share.	29 Jan 2026	28,335	96,708 (0%)	0%	6.4	182,390	Common Stock
Solid Biosciences Inc	Gabriel Brooks	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	28,225	125,043 (0%)	0%		-	Common Stock
Solid Biosciences Inc	Gabriel Brooks	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	28,225	84,675	-		-	Restricted Stock Units
Lithium Americas Corp	Alexi Zawadzki	VP, Resource Development	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	28,149	28,149	-		-	Restricted Stock Units
Ethos Technologies Inc Board Meeting	Roelof Frederik Botha	Director, Ten Percent Owner		29 Jan 2026	27,837	0	-		-	Series C Preferred Stock
Solid Biosciences Inc	Jessie Hanrahan	Chief Regulatory Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	27,625	109,210 (0%)	0%		-	Common Stock
Solid Biosciences Inc	Jessie Hanrahan	Chief Regulatory Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	27,625	82,875	-		-	Restricted Stock Units
Archrock Inc	Stephanie Hildebrandt	SVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	27,425	411,127 (0%)	0%		0	Common Stock
Noble Corp PLC (Class A)	Richard B. Barker	EVP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	27,371	70,779	-		-	Restricted Stock Units
Public Policy Holding Company	George Stewart Hall	Executive Director,Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 12.25 per share.	29 Jan 2026	27,322	1,266,334 (4%)	0%	12.3	334,695	Ords 0.00p
Aeluma Inc	Mark N. Tompkins	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 16.75 per share.	29 Jan 2026	27,297	1,892,691	-	16.8	457,225	Common Stock
Viemed Healthcare Inc	W. Todd Zehnder	Director, Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	26,842	401,677	-		-	Common Shares
Viemed Healthcare Inc	W. Todd Zehnder	Director, Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	26,842	26,842	-		-	Restricted Stock Units
Viemed Healthcare Inc	Michael Moore	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	26,842	196,432	-		-	Common Shares
Viemed Healthcare Inc	Michael Moore	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	26,842	26,842	-		-	Restricted Stock Units
Solid Biosciences Inc	Kevin Tan	CFO & Treasurer	Sale of securities on an exchange or to another person at price $ 6.44 per share.	29 Jan 2026	26,837	108,984 (0%)	0%	6.4	172,747	Common Stock
Solid Biosciences Inc	Jessie Hanrahan	Chief Regulatory Officer	Sale of securities on an exchange or to another person at price $ 6.44 per share.	29 Jan 2026	26,535	82,675 (0%)	0%	6.4	170,803	Common Stock
Caesars Entertainment	Thomas R. Reeg	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.28 per share.	29 Jan 2026	26,438	362,231 (0%)	0%	21.3	562,601	Common Stock
AT&T Legal Settlement	Sabrina Sanders	SVP-ChiefActngOfcr&Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	26,350	29,388 (0%)	0%		-	Common Stock
Solid Biosciences Inc	Paul Herzich	Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 6.44 per share.	29 Jan 2026	26,250	79,972 (0%)	0%	6.4	168,969	Common Stock
Lithium Americas Corp	Aubree Barnum	VP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	26,199	26,199	-		-	Restricted Share Units
Lithium Americas Corp	Timothy Ambrose Crowley	VP, Gov & External Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	26,199	26,199	-		-	Restricted Share Units
TSS Inc	Darryll E. Dewan	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.20 per share.	29 Jan 2026	25,960	599,471	-	11.2	290,752	Common Stock
Lithium Americas Corp	Aubree Barnum	VP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	25,613	95,886	-		0	Common Shares
Lithium Americas Corp	Timothy Ambrose Crowley	VP, Gov & External Affairs	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	25,490	160,914	-		0	Common Shares
Beam Therapeutics Inc	John Evans	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	25,000	68,672	-		-	Stock Option (Right to Buy)
Beam Therapeutics Inc	John Evans	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share.	29 Jan 2026	25,000	1,011,667 (2%)	0%	0.7	16,750	Common Stock
Lightbridge Corp	Andrey Mushakov	EVP, Nuclear Operations	Sale of securities on an exchange or to another person at price $ 16.54 per share.	29 Jan 2026	24,929	391,909 (12%)	0%	16.5	412,425	Common Stock
Postal Realty Trust Inc - Ordinary Shares Cls A	Andrew Spodek	Director, CEO and Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	24,736	38,831 (0%)	0%		0	Class A common stock
Solid Biosciences Inc	Paul Herzich	Chief Technology Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	24,675	74,025	-		-	Restricted Stock Units
Solid Biosciences Inc	Paul Herzich	Chief Technology Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	24,675	106,222 (0%)	0%		-	Common Stock
First Horizon Corp Results Board Meeting	D. Bryan Jordan	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 24.17 per share.	29 Jan 2026	24,115	870,533 (0%)	0%	24.2	582,860	Common Stock
Aeluma Inc	Mark N. Tompkins	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 15.88 per share.	29 Jan 2026	24,092	1,863,396	-	15.9	382,581	Common Stock
Archrock Inc	Jason G. Ingersoll	SENIOR VICE PRESIDENT	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	23,997	286,312 (0%)	0%		0	Common Stock
Archrock Inc	Eric W. Thode	SENIOR VICE PRESIDENT	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	23,997	194,744 (0%)	0%		0	Common Stock
Texas Instruments	Ahmad Bahai	Sr. Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	23,458	23,458	-		-	NQ Stock Option (Right to Buy)
PubMatic Inc Ordinary Shares	Rajeev K. Goel	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner		29 Jan 2026	23,389	210,984	-		-	Class B Common Stock
PubMatic Inc Ordinary Shares	Rajeev K. Goel	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	23,389	234,373	-		-	Class B Common Stock
PubMatic Inc Ordinary Shares	Rajeev K. Goel	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	23,389	245,462	-		-	Stock Option (Right to buy Class B Common Stock)
PubMatic Inc Ordinary Shares	Rajeev K. Goel	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner		29 Jan 2026	23,389	44,000	-		-	Class A Common Stock
Lithium Americas Corp	Robert Russell-Smith	SVP, Finance	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	23,377	23,377	-		-	Restricted Share Units
Caesars Entertainment	Edmund L. Quatmann	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	23,269	107,612 (0%)	0%		0	Common Stock
Noble Corp PLC (Class A)	Joey M. Kawaja	SVP, Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	23,171	54,000	-		-	Restricted Stock Units
Waste Management	James C. Fish	Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 226.41 per share.	29 Jan 2026	22,763	256,840 (0%)	0%	226.4	5,153,771	Common Stock
Caesars Entertainment	Anthony L. Carano	President and COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	22,574	45,690	-		-	Restricted Stock Units
PPL	Joseph P. Bergstein	EVP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	22,245	22,245	-		-	Performance Stock Unit (SIP)
Beam Therapeutics Inc	John Evans	Director, CEO	Sale of securities on an exchange or to another person at price $ 28.27 per share.	29 Jan 2026	22,094	989,573 (1%)	0%	28.3	624,672	Common Stock
AT&T Legal Settlement	Kellyn Smith Kenny	Chief Marketing & Growth Ofcr	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	22,009	0 (0%)	0%		-	Common Stock
Northern Trust 10-year high	Michael G. O'Grady	Director, Chairman and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 150.78 per share.	29 Jan 2026	21,739	361,818 (0%)	0%	150.8	3,277,806	Common Stock
PubMatic Inc Ordinary Shares	Rajeev K. Goel	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 7.32 per share.	29 Jan 2026	21,592	20,611	-	7.3	157,982	Class A Common Stock
QuidelOrtho Corporation	Brian J. Blaser	President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	21,446	32,897 (0%)	0%		0	Common Stock
QuidelOrtho Corporation	Brian J. Blaser	President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	21,446	42,892	-		-	Restricted Stock Units
AT&T Legal Settlement	Kellyn Smith Kenny	Chief Marketing & Growth Ofcr	Sale or transfer of securities back to the company at price $ 0.00 per share.	29 Jan 2026	21,275	0 (0%)	0%		-	Common Stock
Enphase Energy	Mandy Yang	EVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2026	21,120	111,227 (0%)	0%		0	Common Stock
Corning	Edward A. Schlesinger	Exec. Vice President and CFO	Sale of securities on an exchange or to another person at price $ 104.55 per share.	29 Jan 2026	21,104	54,780 (0%)	0%	104.5	2,206,326	Common Stock
Caesars Entertainment	Stephanie D. Lepori	CAO & Chief Admin. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	29 Jan 2026	21,072	87,620 (0%)	0%		0	Common Stock
Caesars Entertainment	Anthony L. Carano	President and COO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.28 per share.	29 Jan 2026	21,014	302,867 (0%)	0%	21.3	447,178	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Jan 29, 2026

Monitor US insider transactions and discover insider buying and selling of stocks on Jan 29, 2026.

Screeners based on Insider Trading parameters